Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorMSD Italia S.r.l.

About this trial

Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.

Eligibility criteria

Qualifiers

Patient (or their legally acceptable representatives) must have signed and dated the Informed Consent & Privacy Form (ICF)

Age ≥18 years

Diagnosis of a cervical cancer

Locally advanced stage (not suitable for curative surgery) or recurrent or metastatic disease

Disqualifiers

Patients participating in a pharmacological clinical trial for the treatment of advanced disease

Patients who participated in a clinical trial

Patients who were administered with Pembrolizumab, Olaparib or Levantinib or medications from these class of drugs

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators